新聞/Reuters/Annexon says enrollment of Phase 3 Archer II Trial expected to be completed in Q3 2025Annexon says enrollment of Phase 3 Archer II Trial expected to be completed in Q3 2025Refinitiv閱讀少於1分鐘ANNXAnnexon Inc ANNX:ANNEXON INC - ENROLLMENT OF PHASE 3 ARCHER II TRIAL EXPECTED TO BE COMPLETED IN Q3 2025, WITH TOPLINE DATA EXPECTED IN SECOND HALF OF 2026Reuters美國股票© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html顯示更多登入或建立一個永久免費帳戶來閱讀此新聞讓我們開始吧
